Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
02/19/2009 | WO2009021944A1 New compounds |
02/19/2009 | WO2008148057A3 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
02/19/2009 | US20090048372 Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate |
02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
02/19/2009 | US20090048224 Compounds and methods of use |
02/19/2009 | CA2696556A1 New compounds |
02/19/2009 | CA2696261A1 New compounds |
02/19/2009 | CA2695636A1 Bicyclic acylguanidine derivative |
02/18/2009 | EP2025673A1 Arylsulfonamides with analgetic activity |
02/18/2009 | EP2024359A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's decease and/or schizophrenia |
02/18/2009 | EP2024350A1 Piperidine derivatives as human papilloma virus inhibitors |
02/18/2009 | EP1641775B1 2-pyridine alkyne derivatives useful for treating pain |
02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
02/18/2009 | CN101370779A Cyclohexyl sulfonamide derivatives having H3 receptor activity |
02/18/2009 | CN101370773A Cycloalkanecarboxamide derivative and method for producing same |
02/17/2009 | US7491821 2-(4-fluorophenyl)-4-propyl-oxazole-5-carboxylic acid {2-[4-(6-aminopyridin-2-yl)-piperazin-1-yl]-1-methyl-ethyl}amide; purinergic receptor antagonists, analgesics; urogenital, gastointestinal and respiratory system disorders |
02/17/2009 | US7491741 Diaminopropionic acid derivatives |
02/17/2009 | US7491727 Arylpiperazinyl compounds |
02/17/2009 | US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use |
02/17/2009 | US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma |
02/17/2009 | CA2157143C Alkylbenzoylguanidine derivatives |
02/12/2009 | WO2009020198A1 Aniline derivative having anti-dna virus activity |
02/12/2009 | WO2008139481A3 Proton acceptor iminium/carbocation-type coupling agents |
02/12/2009 | WO2008104582A3 Novel method for producing teta by means of eddn |
02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
02/12/2009 | US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
02/12/2009 | US20090042920 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
02/12/2009 | US20090042907 Bicyclic aromatic sulfinyl derivatives |
02/12/2009 | US20090042899 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
02/12/2009 | US20090042886 Benzamide Inhibitors of the P2X7 Receptor |
02/12/2009 | US20090042855 BENZAMIDE mGluR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME |
02/12/2009 | US20090041663 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
02/11/2009 | CN101362738A Method for preparing cinepazide maleate |
02/10/2009 | US7488844 Therapeutic agents |
02/10/2009 | US7488731 Arylpiperazinyl compounds |
02/10/2009 | US7488730 N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-phenyl-1-piperazinealkylamide derivatives, and therapeutic use thereof as 5-HT7 receptor ligands |
02/10/2009 | CA2349452C Therapeutic agents for drug dependence |
02/10/2009 | CA2336691C Ligands for metals and metal-catalyzed processes |
02/10/2009 | CA2328396C New substituted amides, their production and their use |
02/05/2009 | WO2009016414A1 Novel process |
02/05/2009 | WO2009016286A2 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
02/05/2009 | WO2009016085A1 Spiro compounds useful as antagonists of the h1 receptor |
02/05/2009 | WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
02/05/2009 | US20090036450 Pyrazole compounds and use thereof |
02/05/2009 | US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
02/05/2009 | US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
02/05/2009 | US20090036419 Compounds useful as raf kinase inhibitors |
02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
02/05/2009 | CA2694608A1 A process for the preparation of almotriptan and a synthetic intermediate usable in said process |
02/05/2009 | CA2691866A1 6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof |
02/04/2009 | EP1565422B1 Vitamin d receptor modulators |
02/04/2009 | CN101360728A Iap bir domain binding compounds |
02/04/2009 | CN101360727A Process for the preparation of a pharmaceutical intermediate |
02/04/2009 | CN101360726A Method for producing tertiary amine |
02/04/2009 | CN101360706A (R)-arylalkylamino derivatives and pharmaceutical compositions containing them |
02/04/2009 | CN100457738C Aryloxyphenyl and arylsulfanylphenyl piperazine derivatives |
02/04/2009 | CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
02/03/2009 | US7485651 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects |
02/03/2009 | US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
02/03/2009 | US7485631 macrolactone antibiotics; Phorboxazole mimetics; carcinogenic agent; cancer cell division inhibitor; pancreatic, breast, non-small lung, colon, and prostate cancers, leukemia |
02/03/2009 | CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
01/29/2009 | WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
01/29/2009 | US20090030197 Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof |
01/29/2009 | US20090029999 Synephrine derivatives useful as anti-inflammatory agents |
01/29/2009 | US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
01/29/2009 | US20090029985 Pyridazine compounds and methods |
01/29/2009 | US20090029858 Spirocyclic 3'-Alkoxytetramic Acids and -Tetronic Acids |
01/29/2009 | CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
01/28/2009 | EP2019097A1 Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine |
01/28/2009 | EP2019096A1 Process for obtaining Cetirizine dihydrochloride |
01/28/2009 | EP1670761B1 Tetrahydro-naphthalene and urea derivatives |
01/28/2009 | EP1542687B1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
01/28/2009 | CN101356164A Novel compounds |
01/28/2009 | CN101356163A Sulfanyl substituted phenyl methanones as glycine transporter 1 (GlyT-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
01/28/2009 | CN101356162A Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates |
01/28/2009 | CN101356149A Indene derivatives, their preparation and use as medicaments |
01/28/2009 | CN101353321A 3-amino-piperadine derivatives and methods of manufacture |
01/28/2009 | CN101353313A Process to produce oxazolidinones |
01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
01/28/2009 | CN100455565C Sulfonamide anions as catalysts for nco oligomerization |
01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
01/27/2009 | US7482448 Compounds and compositions as cathepsin inhibitors |
01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
01/27/2009 | US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists |
01/27/2009 | US7482022 Palatable chewable tablet |
01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
01/22/2009 | WO2009012201A2 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides |
01/22/2009 | WO2009010522A1 Aldimines and compositions comprising aldamine |
01/22/2009 | US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms |
01/22/2009 | US20090023750 Novel salts of piperazine compounds as d3/d2 antagonists |
01/22/2009 | US20090023747 Cysteine Protease Inhibitors |
01/22/2009 | US20090023735 Sulphonamide Derivatives |
01/22/2009 | US20090023734 Treating cell proliferative disorders |
01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
01/22/2009 | DE102008002923A1 Verfahren zur Hestellung von tertiären Alkylestern der(Meth)Acrylsäure mit mindestens 4 Kohlenstoffatomen im Alkylrest A process for the operations department of tertiary alkyl esters of (meth) acrylic acid having at least 4 carbon atoms in the alkyl radical |
01/21/2009 | EP2017260A1 Aldimines and compounds containing aldimine |